Dr. Elias H. Botvinick, MD

Dr. Botvinick practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Botvinick's NPI, 1760440465, was assigned on May 2, 2006. Dr. Botvinick graduated from New York University School of Medicine in 1967. Dr. Botvinick holds California license G22161.

Dr. Botvinick's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Botvinick's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Botvinick to 3 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Botvinick practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Botvinick's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Botvinick is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Botvinick's licenses on file in 4 states: California, New York, Florida and Ohio.

Dmand AI lists atrial fibrillation and flutter, chronic hypertension, coronary artery disease and heart failure among the conditions Dr. Botvinick treats.

CMS data shows 27 Medicare services from Dr. Botvinick across 1 procedure code in 2024, all of them office visits, for 19 Medicare patients. Medicare paid $2,149 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 19 Medicare patients who saw Dr. Botvinick in 2024. 75% of them have diabetes, and 75% have heart failure. Their average risk score is 3.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Botvinick's median patient age at 85, with 13% women.

In 2024, Dr. Botvinick wrote 140 Medicare Part D claims for 26 patients. 89% of them were for generic drugs. CMS names the drug for 75 of them, across 4 drugs with 11 or more claims each, at $1,216 in total drug cost. In 2023, CMS named 81 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Botvinick for performance year 2024, reported as part of a group. Dr. Botvinick accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 157 papers to Dr. Botvinick, published from 2014 to 2020. 2015 was the busiest year, with 5. The most frequent topics are Radionuclide Imaging, Heart and Coronary Disease. Dr. Botvinick has published most often in Circulation. Dr. Botvinick's most frequent co-authors are Michael W. Dae, MD, Nelson B. Schiller, MD and Melvin M. Scheinman, MD.

Dmand AI links Dr. Botvinick to 1 clinical trial. Conditions studied include Ischemia and Coronary Artery Disease.

Dmand AI lists 2 awards for Dr. Botvinick, most recently CMS Stage 1 EHR in 2013.

Dr. Botvinick graduated from New York University School of Medicine in 1967. Dr. Botvinick is a member of ACC.

Dr. Botvinick is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.